Grace Linton, RA, AIA, LEED AP BD+C

Process Architect

San Diego, CA

Grace Linton has delivered projects in North America, Europe and Asia, covering a wide range of facility types, including monoclonal antibodies, vaccines, blood fractionation, active pharmaceutical ingredients, oral solid dosage, medical devices, fill finish, oligonucleotides and cell and gene therapies. As a lead process architect for designing Current Good Manufacturing Practice (CGMP) biopharmaceutical facilities, Linton is responsible for integrating the client’s goals and programming criteria, regulatory requirements and building codes and standards into a cohesive facility concept.

Linton’s design acumen is evident in design workshops where she draws from her broad knowledge in process, equipment and technology, CGMP operations and flows, and building systems to deftly construct a facility concept. Her dynamic design approach is supplemented by real-time 3-D modeling that serves as a communication tool for visualizing and exploring spatial concepts. Linton has a Bachelor of Arts in architecture from Washington University in St. Louis.

“My approach for designing a facility is to take a set of complex challenges and distill them down to a simple, elegant and innovative solution. I welcome new perspectives, input and challenges as they lead to a more robust design. Many of my recent projects are cell and gene therapy facilities. I am energized by the hope and optimism in this emerging field, and I enjoy the intellectual challenge of learning new science and technologies. But most of all, I am motivated by the therapies and cures these products offer to people living with debilitating and life-threatening conditions. As a process architect, it is my responsibility and privilege to approach each project with the goal of ensuring product protection, operator safety and lean design and operations for maximum throughput.”

Insights By Grace

Standard Facility Design

Expanding global operations with standard facility design

Increasingly, manufacturers want standard facility designs of their GMP manufacturing facilities so they can be replicated elsewhere in the world, but this approach comes with unique considerations.

Read More
virus cell in life sciences

5 current trends that will shape the life sciences in 2021 and beyond

Many of the life sciences trends that are driving innovation today were here pre-COVID, but the pandemic was an accelerant. For all that it took, it gave life science researchers and developers new momentum, and from that momentum, hope.

Read More
Cell and gene therapy

Cell and gene therapy facility design molded by commercial biopharma experience

Interview with Niranjan Kulkarni, Senior Director, Allan Bream, Process Specialist, and Grace Linton, Process Architect at CRB that originally appeared in Cell and Gene Therapy Insights, on how commercial biopharma experience is shaping cell and gene therapy facility design.

Read More
ATMP

Choose your playing field: ATMP site selection

So you want to build a new facility for advanced therapy manufacture? Before you start building, there is one essential element that you need to get right: site selection.

Read More
An artistic portrayal of adeno-associated viral vectors used in gene therapy manufacture

Advanced therapy medicinal product facilities through the eyes of a process architect

Advanced therapy medicinal product (ATMP) companies are ushering in a new frontier of medicine and technologies poised to revolutionize human health.

Read More